Skip to content
Sulfacytine
Renoquid (sulfacytine) is a small molecule pharmaceutical. Sulfacytine was first approved as Renoquid on 1982-01-01. It is used to treat gram-negative bacterial infections, gram-positive bacterial infections, and urinary tract infections in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
urogenital diseasesD000091642
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Sulfacytine
Tradename
Company
Number
Date
Products
RENOQUIDGlenwoodN-017569 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
gram-negative bacterial infectionsD016905
gram-positive bacterial infectionsD016908
urinary tract infectionsEFO_0003103D014552N39.0
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
3 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Meibomian gland dysfunctionD000080343H02.8811
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C8011
Neoplasm metastasisD009362EFO_000970811
Neoplastic processesD00938511
Prostatic neoplasmsD011471C6111
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSULFACYTINE
INNsulfacitine
Description
Sulfacytine is a member of benzenes and a sulfonamide.
Classification
Small molecule
Drug classantimicrobials (sulfonamides derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCn1ccc(NS(=O)(=O)c2ccc(N)cc2)nc1=O
Identifiers
PDB
CAS-ID17784-12-2
RxCUI78902
ChEMBL IDCHEMBL1201056
ChEBI ID
PubChem CID5322
DrugBankDB01298
UNII IDT795873AJP (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 14 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
648 adverse events reported
View more details